Pre-Feasibility Reportenvironmentclearance.nic.in/writereaddata/Online/TOR/01... · 2017. 4. 1. ·...
Transcript of Pre-Feasibility Reportenvironmentclearance.nic.in/writereaddata/Online/TOR/01... · 2017. 4. 1. ·...
Pre-Feasibility Report
For
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil Nadu
Submitted by
Anjan Drug Private Limited
Head Office 5th Floor, Nelson Towers, II Wing, 117, Nelson Manickam Road, Aminjikarai, Chennai, Tamil Nadu, India-600029
Plant M/s .Anjan Drug Private Ltd ·
85-88,105-109,112-116, .Export Promotion Industrial Estate SIPCOT,
Industrial Estate; Gummidipoondi Thiruvallur District,·Tamil Nadu
March 2017
Page 2 of 36
Proponent Declaration
M/s Anjan Drug Private Limited, Tamil Nadu has prepared the “Pre- Feasibility Report
(PFR)” for Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi at its existing facility
The PFR report preparations have been undertaken in compliance with the MoEF&CC.
Information and content provided in the report is factually correct for the purpose
and objective for such study undertaken.
We hereby declare the ownership of contents (information and data) of Form -1 and PFR Report.
On behalf of Anjan Drug Private Limited
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 3 of 36
Table of Contents 1. INTRODUCTION ......................................................................................................... 7
1.1. About the Company ................................................................................................ 7
1.2. Project of Interest .................................................................................................... 7
1.3. Existing Facility ...................................................................................................... 8
1.4. Project Location Details .......................................................................................... 8
1.5. Overview of the Proposed Project ......................................................................... 12
1.6. Need for the Proposed Products ............................................................................ 12
1.7. Environmental Friendly Operations ....................................................................... 13
1.8. Structure of the Report .......................................................................................... 13
2. DETAILS OF THE EXISITNG FACILITIES ............................................................. 14
2.1. Overview of the Existing Facilities........................................................................ 14
2.2. Manufacturing process of Existing Products .......................................................... 14
2.2.1. Manufacturing Process of Di-Ethyl Di-Proply Malonate (DEDPM) ............... 14
2.2.2. Manufacturing of n-Propyl Bromide (Currently not manufactured due to market
conditions although EC is obtained in 2008) ................................................................ 15
2.2.3. Manufacturing of Gabapentin ......................................................................... 16
2.3. By-Products Generation (Existing Operations) ...................................................... 17
2.4. Electrical Energy Use in the Existing .................................................................... 17
2.5. Existing Land area ................................................................................................ 17
2.6. Existing Environmental Management Plan & Environmental Clearance and
Compliance ..................................................................................................................... 18
2.7. Air Quality Management Plan ............................................................................... 18
2.8. Noise Levels in Existing Facility ........................................................................... 19
2.9. Water Consumption and Wastewater Generation ................................................... 19
2.10. Wastewater Treatment and Disposal .................................................................. 20
2.11. Generation of Solid waste, Treatment & Disposal .............................................. 21
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 4 of 36
3. PROPOSED EXPANSION ACTIVITIES ................................................................... 23
3.1. Overview .............................................................................................................. 23
3.2. Manufacturing Process of Products ....................................................................... 24
3.2.1. Manufacturing of Gabapentin ......................................................................... 24
3.2.2. Manufacturing of Valproic Acid .................................................................... 25
3.2.3. Manufacturing of Pregabalin .......................................................................... 26
3.2.4. Manufacturing of ITO Pride HCl ................................................................... 28
3.3. Augmentation of Existing Plant and Machinery .................................................... 29
3.4. Water Consumption for the Proposed Expansion ................................................... 29
3.5. Wastewater Generation for the Proposed Expansion .............................................. 30
3.6. Solid Waste Generation and Disposal .................................................................... 31
3.7. Steam Demand and Fuel Requirements ................................................................. 31
3.8. Additional Man Power Required ........................................................................... 32
3.9. Power Requirement ............................................................................................... 32
4. PROPOSED ENVIRONMENTAL MANAGEMENT PLAN AND CLEARANCES
REQUIRED ........................................................................................................................ 33
4.1. Control of Air Emissions ....................................................................................... 33
4.2. Noise Control Measures ........................................................................................ 33
4.3. Additional Safety Measures Needed ...................................................................... 34
4.4. Hazardous Substances and Occupational Health Program ..................................... 34
5. Project Cost and Implementation ................................................................................. 36
5.1. Project Cost .......................................................................................................... 36
5.2. Project Timeline .................................................................................................... 36
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 5 of 36
List of Tables
Table 1.1 List of Products Manufactured in the Existing Facility ........................................... 8
Table 1.2 Environmental Settings .......................................................................................... 9
Table 1.3 Details of the Existing Products and Proposed Products ....................................... 12
Table 2.1 Details of the Existing Products Manufactured at the Existing facility.................. 14
Table 2.2 Details of Land Use Breakup .............................................................................. 18
Table 2.3 Air Pollution Sources & Control Measures in the Existing Facility ..................... 19
Table 2.4 Water Requirement for the Existing Plant ........................................................... 19
Table 2.5 Existing ETP units ............................................................................................... 20
Table 2.6 Characteristics of Treated Effluent ....................................................................... 21
Table 2.7 Solid & Hazardous Waste Generation & Disposal Methods ................................ 22
Table 3.1 Details of the Existing and Proposed Products ..................................................... 23
Table 3.2 Details of Land Use Breakup ............................................................................... 29
Table 3.3 Wastewater Generation Details for Existing and Proposed ................................... 31
Table 3.4 Solid Hazardous Waste for Existing and Proposed .............................................. 31
Table 3.5 Steam Demand and Fuel Requirement for Existing & Proposed ........................... 32
Table 4.1 Existing and Proposed Emission Sources ............................................................. 33
Table 5.1 Bar Chart showing the Project Implementation .................................................... 36
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 6 of 36
List of Figures Figure 1-1 Project Location ................................................................................................. 10
Figure 1-2 Google Earth Image of the Project...................................................................... 11
Figure 1-3 10km radius of the Project Site ........................................................................... 11
Figure 2-1 Manufacturing Process of Di-Ethyl Di-Proply Malonate (DEDPM) ................... 15
Figure 2-2 Manufacturing of n-Propyl Bromide................................................................... 16
Figure 2-3 Manufacturing of Gabapentin ............................................................................. 17
Figure 2-4 Water Balance for the Existing Facility .............................................................. 20
Figure 2-5 Zero Liquid Discharge System for the Exisitng Facility ..................................... 21
Figure 3-1 Manufacturing Process of Gabapentin ................................................................ 24
Figure 3-2 Manufacturing Process of Valproic Acid ............................................................ 25
Figure 3-3 Manufacturing Process of Pregabalin ................................................................. 27
Figure 3-4 Manufacturing Process of ITO Pride .................................................................. 28
Figure 3-5 Water Balance for the Proposed Expansion ........................................................ 30
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 7 of 36
1. INTRODUCTION
1.1. About the Company
Anjan Drug Private Limited (ADPL) was founded in 1990 and has grown into a fully
integrated Pharmaceutical API manufacturing Organization, backed with immense
experience in development and manufacturing of bulk drugs. Anjan Drugs is now supplying
the Active Pharma Ingredients (API) to leading Formulation companies across the world. It
is committed for environmental protection as a drive for growth and contributes to value
creation with innovative and sustainable solutions for customers and for many industries form
different countries across the globe. At the same time, ADPL research and development is
focused on addressing the key trends for developing and producing quality ingredients which
are used for curing harmful diseases. Producing superior quality products by finding cost-
effective methods and environmental friendly operations for developing products, enables it
for providing better service.
1.2. Project of Interest
ADPL is operating one of its plants in SIPCOT Export Promotion, Industrial Park (EPIP),
Gummidipoondi, Tiruvallur District, Tamil Nadu for manufacturing bulk drugs. ADPL has
proposed to enhance the production of their existing products and addition of three new
products (Valproic Acid, Pregabalin and ITO pride HCl) based upon the present market
condition. The existing facility is located at the plot no. 85-88,105-109,112-116, SIPCOT
Export Promotion, Industrial Park (EPIP), Gummidipoondi, Tiruvallur District. The existing
land was leased form SIPOCT and the land lease agreement is attached as Annexure-1.The
total land available at facility is 12 acres in which existing facility is operated and proposed
expansion will be carried out within the same land. No additional land will be purchased for
this expansion.
The facility is mainly by surrounded foundries and power plant namely Vibromech-foundry,
RBA exports, Power point industries, JKM Ferro Tech, Abinava Aluminium(p)Ltd and OPG
power plant, Kamchi sponge and power palnt and other plants such as Hi- Tech carbon, etc.
Project site is located from the 9.2 km from the Eco-sensitive zone of Pilicat wildlife and bird
sanctuary as per the MoEF&CC notification S.O.22(E) dated 3/1/2014 and falls under
category A. The notification is attached as Appendix-1 for this report.
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 8 of 36
1.3. Existing Facility
The existing was obtained environmental clearance letter vide no F.No. J-11011/1057/2007-
1A (II) in the year 2008 for manufacturing the bulk drugs presented in Table 1.1
Environmental Clearance obtained for the for the existing is attached as Annexure-2.
Presently the facility is manufacturing only DEDPM and Gabapentin. n-propyl Bromide was
not manufactured till date due to market conditions.
Table 1.1 List of Products Manufactured in the Existing Facility
S.No. Name of the Product Production Capacity
1 Di-Ehtyl Di-Propyle Malonate (DEDPM) 100MTPM 2 n-propyl Bromide* 100MTPM 3 Gabapentin 5 MTPM
*n-propoly Bromide is not manufactured till date due to market conditions although EC is obtained in 2008
The existing facility is designed to manufacture 205TPM of bulk drugs. Due to the market
conditions n-propyl Bromide is not manufactured till date. The production activities are
generally scheduled as per the market demand from time to time within the consented and
approved capacities. The existing facility is having permission to with draw sufficient
quantity of water from SIPCOT and the facility is also availed all the necessary regulatory
permissions such as Hazardous waste authorization and CTE and CTO form the concerned
authorities.
1.4. Project Location Details
The existing production facility of ADPL is located in the SIPCOT, Gummidipoondi,
Tiruvallur district, Tamil Nadu 601201. The Environmental setting of the project site is
presented in the Table 1.2. The general location of the project area is presented in Figure 1.1.
Google Earth imagery showing the project site is given in Figure 1.2. 10 km radius of the
project site is presented in Figure 1.3.
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 9 of 36
Table 1.2 Environmental Settings
S. No. Particulars Details 1 Latitude 13°25'18.61"N 2 Longitude 80° 6'14.80"E 3 Site Elevation above MSL 17m 4 Topography Plain 5 Present land use at the site SIPCOT 6 Nearest highway NH 5 7 Nearest railway station Gummipoondi 8 Nearest airport Chennai Airport 9 Nearest town / city Gummidipoondi
10 Water body Pulicat Lake (10km from the project site) 11 Nearest Port Chennai port 12 Hills / valleys Nil 13 Archaeologically important places Nil 14 National parks / Wildlife Sanctuaries Pulicat bird Sanctuary 15 Reserved / Protected Forests Nil 16 Seismicity Zone III seismic zone map of India 2002 17 Defence Installations Nil
18 Industries Located in the SIPCOT complex
Vibromech-foundry, RBA exports, Power point industries, JKM Ferro Tech, Abinava Aluminium(p)Ltd and OPG powerplant, Kamchi sponge and power palnt and other plants such as Hi- Tech carbon
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7Jan 2017
Chapter-1
Page 10 of 36
Figure 1-1 Project Location
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-1
Page 11 of 36
Figure 1-2 Google Earth Image of the Project
Figure 1-3 10km radius of the Project Site
Scale
10 km
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-1
Page 12 of 36
1.5. Overview of the Proposed Project
The proposed project involves the increasing the production capacity for two products and
addition of three new products. The details of the existing and proposed products are
presented in Table 1.3. The proposed expansion will be carried out within the existing
production facility and new facility within the existing land will be utilized to manufacture
additional two new products.
The necessary infrastructure in terms of land, water and personnel are readily available. As
the proposed expansion will be carried out within the existing land which belongs to the
ADPL, rehabilitation and resettlement aspects are not envisaged for the proposed expansion.
There will be no significant adverse impact on the environment due to the project since all the
necessary measures are proposed to be adopted.
Table 1.3 Details of the Existing Products and Proposed Products
S. No. Name of Products
Production Capacity (Tons/Month)
Existing Additional Quantities (proposed)
Total After Expansion
Products (Tons/Month) 1. n-Propyl Bromide* 100 - 100 2. Di-Ethyl Di-Propyl Malonate 100 - 100 3. Gabapentin 5 45 50 4. Valproic Acid - 100 100 5. Pregabalin - 20 20 6. Ito Pride HCl - 10 10
Total Capacity 205 175 380
*n-propoly Bromide is not manufactured till date due to market conditions although EC is obtained in 2008.
1.6. Need for the Proposed Products
Bulk drugs manufactured in APDL are the raw material for many medicine manufacturers
around the globe. Enormous amount of bulk drug products from India are exported to Global
markets. To remain as a significant player in the market and to meet the increasing demand of
bulk drugs in India and abroad, ADPL has proposed the expansion of existing capacity along
with three new additional products in the category of bulk drug products.
Proposed Expansion Proposed Products Legend:
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-1
Page 13 of 36
1.7. Environmental Friendly Operations
The facility has been adopting a robust environmental management programs and have been
achieving the regulatory compliance in the existing facility. The facility was issued
environmental compliance by MOEF, vide letter no. F.No. J-11011/1057/2007-1A (II), dated
February 27th 2008 and obtained CTE, CTO from the concerned authority TNPCB are given
in Annexure 3.
The consent to operate under Air (Prevention) and Control of Pollution Act and Water
(Prevention) and Control of Pollution Act are obtained as per the norms and guidelines of the
Tamil Nadu Pollution Control Board (TNPCB) from time to time.
1.8.Structure of the Report
This Pre-feasibility report consists of five chapters:
Chapter 1: Introduction and Justification of the Project
Chapter 2: Details of Existing Facilities and Summary of Environmental Compliance
Chapter 3: Details of Proposed Expansion Activities
Chapter 4: Proposed Environmental Management Plan & Clearances Required
Chapter 5: Project Cost & Implementation
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 14 of 36
2. DETAILS OF THE EXISITNG FACILITIES
2.1. Overview of the Existing Facilities
ADPL is having the capacities for producing 205 TPM of bulk drugs in the existing facility.
The details of the existing products are presented in Table 2.1. The summary of existing
facility and proposed project configuration is presented in Annexure 4. The existing peak
capacity is 205 TPM and current operating capacity is only 105TPM as the existing plant is
not manufacturing n-Propyl Bromide due to market conditions.
Table 2.1 Details of the Existing Products Manufactured at the Existing facility
S. No. Name of Products Production Capacity (Tons/Month)
Products (Tons/Month) 1. Di-Ethyl Di-Propyl Malonate 100 2. n-Propyl Bromide* 100 3. Gabapentin 5
Total Capacity 205 *n-propoly Bromide is not manufactured till date due to market conditions although EC is obtained in 2008.
2.2. Manufacturing process of Existing Products
2.2.1. Manufacturing Process of Di-Ethyl Di-Proply Malonate (DEDPM)
Diethyl Malonate react with n-Propyl Bromide in presence of NaOH to give Diethyl di propyl
malonate. After washing Sodium bromide isolated and DEDPM is separated. Sodium
Bromide formed during the process is isolated separately and packed for sales as by product.
C7H12O4 +2C3H7Br + 2NaOH C13H24O4 + 2 NaBr + H2O
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 15 of 36
Total Process Hrs: 26.0 Hrs
1.0 Ton DEDPM preparation - outlet Effluent 1.455 (Tons) of sodium bromide in Aqueous
Medium.
Figure 2-1 Manufacturing Process of Di-Ethyl Di-Proply Malonate (DEDPM)
2.2.2. Manufacturing of n-Propyl Bromide (Currently not manufactured due to
market conditions although EC is obtained in 2008)
Propanol reacts with Sodium bromide (received from DEDPM) in the presence of sulphuric
acid medium to give n-Propyl Bromide. Sodium Sulphate formed during this process is
isolated separately and packed for sales as by product.
2C3H8O + 2NaBr + H2SO4 2C3H7Br + Na2SO4 + 2H2O
Reactors
Reflux
Cooling & Washing
DEM +
n-PBr +
NaOH
H2O
NaBr
DEDPM
n-Propyl Bromide By Product
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 16 of 36
Total Process Hrs: 50.0 Hrs
Output Product: 1.0 Ton n-propyl bromide; Output Effluent: 4.3Tons (Na2SO4 in Aqueous
medium)
Figure 2-2 Manufacturing of n-Propyl Bromide
2.2.3. Manufacturing of Gabapentin
1,1Cyclohexane di acetic mono amide reacts with Sodium Hypochlorite in the presence of
sodium hydroxide medium, and Hydrochloric acid to give Gabapentin, and Sodium Chloride
formed during neutralization stage is isolated separately and packed for sales.
C10H17NO3 + NaOCl+ NaOH+ HCl C9H17NO2 + NaCl + CO2 + H2O
N-Propanol +H2SO4
Reflux
Cooling & Layer separation
Na2SO4
NaBr
Water
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 17 of 36
Total Process Hrs: 50.0 Hrs
Output Product: 1.0 Ton; Output Effluent: 7.8 Tons (NaCl in Aqueous medium)
Figure 2-3 Manufacturing of Gabapentin
2.3. By-Products Generation (Existing Operations)
Besides the production of main products, Sodium Bromide and Sodium Chloride are being
produced as by-products from the processing of main products.
2.4. Electrical Energy Use in the Existing
The existing plant’s connected load is 1302KW (1041KVA) and having a peak load of
379kW (474 KVA).
2.5.Existing Land area
The existing land was leased form SIPCOT. The total land leased is 12acres in which existing
plant is operated and proposed expansion will be carried out within the same land. The land
lease document for 12 acres from SIPOCT is attached as Annexure-1.
Reactor
Neutralization
Cooling & Chilling
Centrifuge
Drying
Amide Sodium Hypo Chloride Sodium Hydroxide,
HCl
Purified Water
NaCl
Gabapentin
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 18 of 36
Table 2.2 Details of Land Use Breakup
S.No Land use Area in Acres 1 Built up Area 0.343 2 Vacant Area 8
3 Soild Waste Storage/Disposal area 0.66
4 Green Belt Area 3 Total 12
2.6. Existing Environmental Management Plan & Environmental Clearance and
Compliance
The facility has been adopting a robust environmental management programs and have been
achieving the regulatory compliance in the existing facility. The facility was issued
environmental compliance by MOEF, vide letter no. F.No. J-11011/1057/2007-1A (II), dated
February 27th 2008 and obtained CTE, CTO form the concerned authority TNPCB.
The consent to operate under Air (Prevention) and Control of Pollution Act and Water
(Prevention) and Control of Pollution Act are obtained as per the norms and guidelines of the
Tamil Nadu Pollution Control Board (TNPCB) from time to time.
2.7.Air Quality Management Plan
The major air pollution sources of the existing plant are Boiler, DG set (occasionally) and
fugitive emission from process activities. ADPL have already installed adequate Air Pollution
Control Measures to conform with the norms of National Ambient Air Quality Standards
(NAAQS). The details of the existing air pollution sources with control measures are
presented in Table 2.3
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 19 of 36
Table 2.3 Air Pollution Sources & Control Measures in the Existing Facility
S.No Source Air Pollution Control Measure
Height (m) ground level
1 DG set 2x320 KVA Stack 13.5 2 Boiler 3T Stack 30 3. Reactor Falling film venture scrubber
Stack emission monitoring was undertaken by Tamil Nadu Pollution Control Board once in
six months. SPM, SO2 and NOX parameters are monitored by MOEF approved laboratory
and also TNPCB. The test reports of Air Quality Monitoring and stack emission monitoring
undertaken by Tamil Nadu State Pollution Control Board (TNPCB) are presented in
Annexure 5.
2.8. Noise Levels in Existing Facility
The Noise Level Monitoring has been monitored by the TNPCB once in six months. Five
locations were selected to monitor for noise levels in the existing plant. The test reports of
noise monitoring from the TNPCB are given in Annexure 6. Noise levels at the facility are
well within the stipulated levels.
2.9. Water Consumption and Wastewater Generation
Water required for the plant is met through the supplies from SIPCOT. The SIPCOT water
allocation letter is attached as Annexure 7. The existing water consumption is 25.5m3/day
and the details of the same are presented in Table 2.4 and the water balance diagram is
presented in Figure 2.1.
Table 2.4 Water Requirement for the Existing Plant
Unit Water requirement (m3/day)
Reactor 15 Boiler & Cooling Tower make up 8 Domestic & Gardening 2.5
Total 25.5
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 20 of 36
Figure 2-4 Water Balance for the Existing Facility
2.10. Wastewater Treatment and Disposal
The existing plant effluent generated is about 12m3/day and is treated in existing ETP having
capacity of 18m3/day and consisting of the following equipments presented in Table 2.5 and
the block diagram of the ETP is presented in Figure 2.2 .
Table 2.5 Existing ETP units
Sl.No Name of the Treatment Unit No of Units
Dimensions (meters)
1. Collection Tank 1 5x5.2x5.75 2. Flash Mixer 1 2.5x2.4x2.5 3. Flocculator 1 2.5x2.4x2.5 4. Primary Settling tank 1 5x5.2x5.75 5. Filter feed tank 1 5x5.2x5.75 6. Pressure sand filter 1 10m3/hr 7. Activated Carbon Filter 1 10m3/hr 8. RO unit 1 6m3/hr 9. Mechanical Evaporator 1 750 l/h
10. Solar Evaporation Pan 12 10.6x7.4x0.3 each
All the Units are in m3/day
Fresh Water 25.5
Reactors Boiler &Cooling
Tower
Domestic & Gardening
ETP
Solar Evaporation
Ponds
15
8
8
4
2.5
12
12
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 21 of 36
Figure 2-5 Zero Liquid Discharge System for the Exisitng Facility
The ETP outlet & MEE Reject is collected and tested by TNPCB District Environmental
Laboratory, Ammbattur. The analysis is presented in Table 2.6 and the analysis report is
attached as Annexure 8.
Table 2.6 Characteristics of Treated Effluent
S.NO Parameter Unit Value
ETP outlet
MEE Reject
1 pH - 6.55 6.88 2 TSS mg/l 114 16 3 TDS mg/l 1530 286 4 BOD at 270Cfor 3days mg/l 155 3 5 COD mg/l - 40
2.11. Generation of Solid waste, Treatment & Disposal
ADPL has obtained Hazardous waste authorization letter from the TNPCB which was
obtained on 18/08/2015 and valid for five years. The details of the hazardous and non
Collection Tank
Flash Mixer
Primary
Settling Tank
Activated
Carbon Filter
Pressure
Sand Filter
RO
Flocculator
MEE
SEP
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-2
Page 22 of 36
hazardous waste generated are presented in Table 2.7. The Hazardous waste authorization
letter from TNPCB is attached as Annexure 9.
Table 2.7 Solid & Hazardous Waste Generation & Disposal Methods
S. No. Type of Waste Category Peak
generation Quantities
Current Disposal method
Hazardous
1
Production/formulation of drugs/pharmaceuticals & health care product(Schedule I)
28.1 10 TPA Recover and reuse CPCB authorized recycler
2
Purification and treatment of exhaust water and waste water from the processes in this schedule and CETPs (Schedule I)
34.3 2 TPA Recover and reuse CPCB authorized recycler
Non-hazardous 1 Food waste - 200 Kg/month Piggery yard
2 Plastic waste - 50 Kg/month Sold to the authorized dealers
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 23 of 36
3. PROPOSED EXPANSION ACTIVITIES
3.1.Overview
ADPL has proposed to enhance the production of their existing product DEDPM and addition
of three new products (Valproic Acid, Pregabalin and ITO pride HCl) based upon the present
market conditions.
The proposed project is for expansion of production of bulk drugs by the addition of other
three new products is presented in Table 3.1.
Table 3.1 Details of the Existing and Proposed Products
S. No. Name of Products
Production Capacity (Tons/Month)
Existing Additional Quantities (proposed)
Total After Expansion
Products (Tons/Month) 1. n-Propyl Bromide* 100 - 100 2. Di-Ethyl Di-Propyl Malonate 100 - 100 3. Gabapentin 5 45 50 4. Valproic Acid - 100 100 5. Pregabalin - 20 20 6. Ito Pride HCl - 10 10
Total Capacity 205 175 380
*n-propoly Bromide is not manufactured till date due to market conditions although EC is obtained in 2008.
The proposed expansion will be carried out within the existing facility. The existing facility is
located at the plot no. 85 to 88, 105, 106,115 and 116, SIPCOT Export Promotion, Industrial
Park (EPIP), Gummidipoondi, Tiruvallur District. The total land area available at the facility
is 12 acres in which existing facility (built up area) is operated and same land will be utilized
for the proposed expansion. No additional land will be purchased for this expansion.
As with the improvement in the technology and sciences ADPL has modified the existing
process according to the “Green Chemistry”. By adopting to this type of technologies the
solvents used in the processes are eliminated and thereby reducing the emissions from the
process.
Proposed Expansion Proposed Products Legend:
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 24 of 36
3.2. Manufacturing Process of Products
3.2.1. Manufacturing of Gabapentin
1,1Cyclohexane di acetic mono amide reacts with Sodium Hypochlorite in the presence of
sodium hydroxide medium, and Hydrochloric acid to give Gabapentin, and Sodium Chloride
formed during neutralization stage is isolated separately and packed for sales.
C10H17NO3 + NaOCl+ NaOH+ HCl C9H17NO2 + NaCl + CO2 +H2O
Total Process Hrs: 50.0 Hrs
Output Product: 1.0 Ton; Output Effluent: 7.8 Tons (NaCl in Aqueous medium)
Figure 3-1 Manufacturing Process of Gabapentin
Reactor
Neutralization
Cooling & Chilling
Centrifuge
Drying
Amide Sodium Hypo Chloride Sodium Hydroxide
HCl
NaCl (Isolation)
Gabapentin
Purified Water
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 25 of 36
3.2.2. Manufacturing of Valproic Acid
Diethyl Malonate react with n-Propyl Bromide in presence of NaOH to give Diethyl di propyl
malonate. After washing Sodium bromide is isolated and DEDPM is separated and
DEDPM on hydrolysis & decarboxylation using Sodium Hydroxide and HCL,
Valproic Acid is obtained.
By-products: Sodium Bromide formed during the process is isolated separately and packed
for sales as by product (from reaction 1). Ethanol & Sodium Chloride from 2nd reaction as by-
products.
C7H12O4 +2C3H7Br + 2NaOH C13H24O4 + 2 NaBr + H2O
C13H24O4 + 2 NaOH +2 HCl C8H16O2 +2NaCl+2C2H6O +CO2
Figure 3-2 Manufacturing Process of Valproic Acid
DEM + n-PBr + NaOH
Valproic Acid
Reactors
Distillation
Water
Neutralization
Decarboxylation
NaCl
HCl
Washing Water
Reactor
Reflux
Cooling & Washing
DEDPM+ NaOH
NaBr
Reflux
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 26 of 36
Total Process Hrs: 56.0 Hrs
Outlet Effluent 1.455 (Tons) of sodium bromide in Aqueous Medium & 4.2 Tons
(NaCl in Aqueous medium) & Ethanol (0.8 Tons).
Output Product: 1.0 Ton Valproic Acid
3.2.3. Manufacturing of Pregabalin
Manufacturing of Pregabalin involves two stages
1. Manufacture of 3- Carbomoylmethyl-5-Methyl Hexanoic Acid
2. Manufacture of Pregabalin using 3- Carbomoylmethyl-5-Methyl hexanoic acid as a
raw material.
Carbomoylmethyl-5-Methyl Hexanoic Acid is manufactured by reacting 3-Isobutyl Glutaric
Acid with Diamide followed by heat reflux and addition of sodium hydroxide. The next step
involves neutralization with HCl, Cooling, Centrifuging and drying. 3-Carbamoylmethyl-5-
methyl Hexanoic acid (R-CMH) react with NaOCl in presence of sodium hydroxide medium
& neutralization using HCl, to give Pregabalin & sodium chloride recovered.
1. 3-Iso butyl glutaric acid to 3- Carbamoyl 5-methyl Hexanoic acid
C9H16O4 + CH4N2O+ NaOH+ HCl C9H17NO3 + NaCl + NH3+CO2 + H2O
Process Hrs: 31.0 hrs
Product : 1.0 Ton, Effluent : 2.014 Ton (NaCl in Aqueous medium)
2. 3-Carbamoyl 5- methyl hexanoic acid to Pregabalin
C9H17NO3 + NaOCl + HCl + NaOH C8H17NO2 +2 NaCl + CO2 + H2O
Process Hrs: 55.0 hrs
Product : 1.0 Ton ; Effluent : 8.232 Tons (NaCl in Aqueous medium)
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 27 of 36
Figure 3-3 Manufacturing Process of Pregabalin
Reactors
Lye addition
Heat Reflux
Neutralization
Cooling & Chilling
Centrifuging
Drying
3-Isobutyl Glutaric Acid, Diamide
NaOH
HCl
NaCl
Carbamoylmethyl-5-methyl Hexonic Acid
Reactors Sodium Hypo Chloride
Hypo chilling
NaCl
Reactor NaoH
Neutralization HCl
Centrifuging
Water
Drying
Pregabalin
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 28 of 36
3.2.4. Manufacturing of ITO Pride HCl
(2-[4 - aminomethyl) phenoxy] N,N-dimethyl Ethan amine) is reacted with Veratroyl
Chloride in presence of anhydrous sodium hydroxide medium. Neutralization using HCl, the
product is isolated and removal of the sodium chloride salt solution. formation of the
ItoPride HCl.
C11H18N2O + C9H9ClO3 + NaOH + HCl
Ito amine Veratroyl Chloride
C20H26N2O4 .HCl + NaCl + H2O
Ito Pride Hydrochloride
Process Hrs: 32.0 hrs
Out Put Product : 1.0 Ton; Out Put Effluent : 1.8 Tons (NaCl in Aqueous medium )
Figure 3-4 Manufacturing Process of ITO Pride
Reactors
Heat Reflux
NaCl
Dissolution
Neutralization
Cooling & Chilling
Centrifuging
Drying
ITO Pride
ITO Amine (2-[4 - aminomethyl phenoxy] N,N-
dimethyl ethanamine ) &
Vertroyl Chloride (3 ,4 -d imethoxy benzoyl chloride)
NaOH
HCl
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 29 of 36
3.3.Augmentation of Existing Plant and Machinery
The proposed project involves expansion of bulk drugs in their existing facility. Hence
naturally no alternative sites are considered. The details of the land break up are as shown in
the Table 3.2. Locations of the proposed facilities to be installed within the existing facility
in the Master Layout are given as Annexure 10.
Table 3.2 Details of Land Use Breakup
S.No Land use Area in Acres 1 Built up Area 0.343 2 Vacant Area 8
3 Solid Waste Storage/Disposal area 0.66
4 Green Belt Area 3 Total 12
3.4.Water Consumption for the Proposed Expansion
At present the total water requirement is 25.5m3/day and after the proposed expansion the
raw water requirement will be increased to 260m3/day which will be sourced from SIPCOT.
In order to maintain environmental friendly operations ADPL has proposed a new quadruple
effect evaporator system with a dedicated 3TPH boiler system. The solids form the ATDF
(Agitated Thin Film Dryer) will be disposed to an authorized vendor.
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 30 of 36
Figure 3-5 Water Balance for the Proposed Expansion
3.5.Wastewater Generation for the Proposed Expansion
After expansion wastewater generated will be 90m3/day out of which 70m3/day of treated
water will be recycled back to the process in the form of condensate. Before going to the
process the condensate is sent to the condensate polishing unit where the losses in this
process will be approximately 20 to 30m3/day and remaining 40m3/day to 50m3/day will be
utilized in the boiler as feed water.
In order to maintain environmental friendly operations ADPL has proposed a new quadruple
effect evaporator system with a dedicated 3TPH boiler system. The solids form the ATDF
(Agitated Thin Film Dryer) will be disposed to an authorized vendor. Wastewater generation
details are presented in Table 3.3.
All the Units are in m3/day
Fresh Water (260m3/day)
Reactors Boiler Cooling Tower Domestic Usage
Gardening
ETP
Quadruple Effect
Evaporator
ATDF
130
50
70
30
25
10
15
15
20
90
90 70
Recycled to Boiler
STP
Solids for disposal Proposed
Units
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 31 of 36
Table 3.3 Wastewater Generation Details for Existing and Proposed
Equipment
Existing Wastewater generation (m3/day)
Proposed Wastewater Generation
(m3/day)
Reactor 8 55 Boiler 2 25 Cooling Tower 2 10
Total 12 90
3.6.Solid Waste Generation and Disposal
The details of solid waste (both hazardous & non-hazardous) generated for existing and post
project scenarios of the plant are given in Table 3.4 along with quantity and disposal
methods. For the new and increased quantity, application will be made to TNPCB for
authorization after getting prior environmental clearance.
Table 3.4 Solid Hazardous Waste for Existing and Proposed
S. No. Type of Waste Category
Existing Peak
generation Quantities
Proposed Peak
generation Quantities
Current Disposal method
Hazardous
1
Production/formulation of drugs/pharmaceuticals & health care product(Schedule I)
28.1 10 TPA
50 TPA
Recover and reuse CPCB authorized recycler
2
Purification and treatment of exhaust water and waste water from the processes in this schedule and CETPs (Schedule I)
34.3 2 TPA 25 TPA
Recover and reuse CPCB authorized recycler
Non-hazardous
1 Food waste - 200 Kg/month 1000 Kg/month
Piggery yard
2 Plastic waste - 50 Kg/month 500 kg/month
Sold to the authorized dealers
3.7.Steam Demand and Fuel Requirements
At present the existing facility is having 3TPH boiler with a steam demand of 0.35TPH. After
the expansion additional 3x2TPH boilers will be installed to fulfill the steam demand for
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-3
Page 32 of 36
process as well as quadruple effect evaporator system. The steam requirement for quadruple
effect evaporator system will be in the range of 0.24 TPH and for process will be to the tune
of 0.64 which will be provided by another boiler.
At present furnace oil of 20KL/month is used as fuel to the existing boiler. Fuel requirement
will be increased to 80KL/Month due to installation of 3x2 TPH Boilers.
Table 3.5 Steam Demand and Fuel Requirement for Existing & Proposed
Particulars Units Existing Additional Proposed Steam Demand TPH 0.35 0.59 0.88
Furnace Oil KL/Month 20 60 80
3.8.Additional Man Power Required
The unit is operated round the clock in three shifts. For the expansion project, additional man
power of 90 Nos. will be deployed. Total number of employees (including contract workers)
after expansion will be 50 nos.
3.9.Power Requirement
The peak demand in the existing plant is about 474 KVA which is being sourced from Tamil
Nadu Generation and Distribution Corporation Limited (TANGEDCO). After the proposed
expansion an additional power of 400 KVA will be required which will also sourced from
TANGEDCO. Total requirement power will be decreased after expansion as the process
technology is going to be changed.
As back-up power 2 no’s of DG sets having capacity of 325 KVA is available in the existing
plant
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-4
Page 33 of 36
4. PROPOSED ENVIRONMENTAL MANAGEMENT PLAN AND
CLEARANCES REQUIRED
4.1.Control of Air Emissions
The main source of emissions from the existing plant is 325KVA DG set and 3TPH boiler.
After expansion the only source for additional increase of emission will be 3TPH boiler. The
details of the existing and proposed emissions and control measures are given in Table4.1.
Table 4.1 Existing and Proposed Emission Sources
Point Emission Sources
Air Pollution Control Measures
Stack Height (m)
DG set 325 KVA Stack 13.5 3 TPH Boiler Stack 26 2x3TPH Boiler (Proposed) Stack (Proposed) --
Fugitive Emission Sources Control Measure
Reactor Falling Film venture scrubber with water media
4.2.Noise Control Measures
Construction Phase
Structural work, deployment of machinery, approach road construction will result in
noise and vehicular traffic. Material handling and transportation would also lead to
significant noise pollution. Continuous exposure of workers to high sound levels may
result in annoyance, fatigue etc. The acceptable limit for each shift being of 8-hour
duration, the equivalent noise level exposure during the shift is 90 dB(A). Hence noise
generation due to excavation may affect workers, if equivalent 8 hours exposure is more than
the safety limit. The workers in general are likely to be exposed to an equipment noise level
of 80-90 dB (A) in an 8 hour shift for which all statutory precautions as per laws will
be taken into consideration. Thus the negative impact will be short-term and reversible
(limited to the duration of the road construction works) and is not considered to be a
significant threat to the health or well being of humans.
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-4
Page 34 of 36
Mitigation Measures
Construction activities generating disturbing sounds will be restricted to normal working
hours
Workers operating equipment which generates noise will be equipped with noise
protective gear. Workers experiencing prolonged noise levels of 70 – 80 dBA should
wear earplugs
Construction activities will be restricted to daytime and no construction will be
practiced during night
To reduce the impact of air and noise pollution and to provide a clean, healthy
environment, a greenbelt area is maintained within the project site and along the
roadsides.
Operation Phase
No significant increase in the noise levels due to the operation of the proposed production
activities is expected. The additional proposed utilities having potential to generate noise are
DG set, Air Compressor, cooling tower and chiller. Noise levels at 1m distance from the
source will be maintained less than 85 dB(A).
4.3.Additional Safety Measures Needed
The safety measures adopted at the existing facility such as fire fighting system, personal
protective equipment are in line with the proposed project expansion. Additional safety
measures for the proposed tank farm will be developed as per the applicable guidelines.
4.4.Hazardous Substances and Occupational Health Program
Chemicals in any form are to be stored, handled and used by thoroughly understanding
their physical, chemical and hazardous properties and necessary precautions will be taken
to avoid any potential hazards. Chemicals will be stored in standard containers like MS,
HDPE, GI Drums, PVC Carboys, etc. All the chemicals will be arranged and stored in
accordance with their compatibility, dry, well ventilated, with flame proof electrical
equipment’s and lighting. All the chemicals will be provided with identification labels.
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-4
Page 35 of 36
Chemical Safety Data Sheets and handling procedure will be prepared and displayed for
information and safety of the working personnel.
As per the guidelines of MoEF, EHS Management Group is formed by ADPL. The
commitment and policy of the company includes the implementation of the Environmental
Management Plan that incorporates all issues related to environmental and social components
and will comply with the suggestions given by the Ministry of Environment and Forests
(MoEF).
Proposed Expansion of the Bulk Drug Unit at SIPCOT, Industrial Estate, Gummidipoondi
by M/s Anjan Drug Private Limited, Tiruvallur District, Tamil
Nadu
Doc NO: PFR/EC/2017 Dated:7 Jan 2017
Chapter-5
Page 36 of 36
5. Project Cost and Implementation
5.1.Project Cost
The estimated project cost for the proposed expansion project is about Rs.32 Crores. out of
which about Rs.7Cr will be spent towards Environmental Protection and management
programs under the expansion program.
5.2.Project Timeline
The bar chart showing the project implementation is given in Table 5.1. The project will be
completed within 9 months form date of obtaining all the required statutory and regulatory
permissions.
Table 5.1 Bar Chart showing the Project Implementation
Sl. No. Description No. of Months
1 2 3 4 5 6 7 8 9
1 Procurement of Equipment
2 Civil & Structural Work
3 Equipment Erection
4 Electricals & Auto machines
5 Tests and Trial Runs
6 EB Yard and related work
7 Commissioning and Trial Production.